Managing Cancer Treatment Side Effects: Customized Pharmacotherapy
Please note that this is the on-demand version of the webinar. The live webinar was recorded on February 14, 2019.
Cancer is one of the leading causes of morbidity and mortality worldwide, with treatment relying heavily on a combination of surgery, chemotherapy, and radiotherapy. While these modalities have improved survival and prognosis for many kinds of cancers, they may have unwanted side effects that not only increase patient suffering but may also hinder compliance. In this webinar, four common treatment-related side effects are reviewed:
- Nausea and vomiting
- Oral mucositis and proctitis
- Dermatologic changes, including acneiform rash, radiation dermatitis and paronychia
- Neuropathic pain.
The pathophysiology behind these conditions and the available treatment options will be discussed with special consideration for customized pharmacotherapeutics. Several extemporaneous formulations will be highlighted in this webinar:
- ABHR (lorazepam, diphenhydramine, haloperidol, metoclopramide)
- Transdermal gel or suppository for nausea and vomiting
- Benzydamine and morphine mouthwashes for oral mucositis
- Sucralfate enema and formalin 10% solution for proctitis
- Ivermectin lotion for acneiform rash
- Heparinoid cream for radiation dermatitis
- BAK (baclofen, amitriptyline, ketamine) cream for neuropathic pain
Lastly, consideration will be made for the role oncology pharmacists can play in optimizing treatment regimens or offering support for cancer patients.
- Pharmacy Technicians
- Nurse Practitioners
- Review the epidemiology of cancer, its clinical presentation and diagnosis, and the treatment options available.
- Discuss the cancer treatment-related symptoms of nausea and vomiting, mucositis, dermatologic changes, and neuropathic pain, focusing on its pathophysiology and its treatment.
- Learn about customized pharmacotherapeutic options to address these treatment-related symptoms
- Explore the expanding role of oncology pharmacists as part of the healthcare team.
- Discover ways through which pharmacists can further support patients battling cancer.
The webinar is copyright © 2019 LP3 Network.
High speed internet connectivity and an updated internet browser is required to attend the webinar. The broadband recommended is 1 Mbps or better. The minimum browser requirements to attend the webinar are:
- Google Chrome v39 or later
- Mozilla Firefox v34 or later
- Internet Explorer v8 or later
- Microsoft Edge
- Apple Safari v6 or later
AARON SIHOTA, BSc, BSc Pharm, RPh
Aaron Sihota is a primary care pharmacist and is presently a Clinical Instructor at the University of British Columbia (UBC) Faculty of Pharmacy. He is the co-creator of the course on Dermatology, Cosmeceuticals, and Topical Compounding at the UBC Faculty of Pharmacy, which is taught to pharmacology students and dermatologists. He also serves on the Canadian Pharmacists Association (CPhA) Dermatology Review Panel as an author and chapter reviewer for the Compendium of Therapeutics for Minor Ailments (CTMA), and he is a regular skincare columnist for the Pharmacy Practice + Business magazine. Given his keen interest in fostering collaborative care between primary care practitioners and specialists, he has developed multiple accredited healthcare education programs and has taught in several conferences across North America.
CANCELLATION AND REFUND POLICY:
There are no refunds, returns or transfer upon purchase of the webinar.